DrugCite
Search

LEUKERAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Leukeran Adverse Events Reported to the FDA Over Time

How are Leukeran adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Leukeran, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Leukeran is flagged as the suspect drug causing the adverse event.

Most Common Leukeran Adverse Events Reported to the FDA

What are the most common Leukeran adverse events reported to the FDA?

Pneumonia
19 (3.34%)
Death
11 (1.93%)
Drug Ineffective
11 (1.93%)
Dyspnoea
11 (1.93%)
Pyrexia
11 (1.93%)
Rash
11 (1.93%)
Anaemia
10 (1.76%)
Cough
9 (1.58%)
Pruritus
8 (1.41%)
Medication Error
7 (1.23%)
Myelodysplastic Syndrome
7 (1.23%)
Show More Show More
Nausea
7 (1.23%)
Neutropenia
7 (1.23%)
Thrombocytopenia
7 (1.23%)
Condition Aggravated
5 (.88%)
Gamma-glutamyltransferase Increased
5 (.88%)
Hepatotoxicity
5 (.88%)
Infection
5 (.88%)
Interstitial Lung Disease
5 (.88%)
Malaise
5 (.88%)
Squamous Cell Carcinoma Of Skin
5 (.88%)
Anorexia
4 (.7%)
Asthenia
4 (.7%)
Back Pain
4 (.7%)
Confusional State
4 (.7%)
Dehydration
4 (.7%)
Drug Administration Error
4 (.7%)
Drug Dispensing Error
4 (.7%)
General Physical Health Deteriorati...
4 (.7%)
Hepatic Necrosis
4 (.7%)
Mouth Ulceration
4 (.7%)
Pneumonitis
4 (.7%)
Prothrombin Time Prolonged
4 (.7%)
Pulmonary Alveolar Haemorrhage
4 (.7%)
Pulmonary Fibrosis
4 (.7%)
Renal Failure Acute
4 (.7%)
Skin Burning Sensation
4 (.7%)
White Blood Cell Count Increased
4 (.7%)
Yellow Skin
4 (.7%)
Contraindication To Medical Treatme...
3 (.53%)
Disease Progression
3 (.53%)
Dizziness
3 (.53%)
Drug Toxicity
3 (.53%)
Dysphagia
3 (.53%)
Fatigue
3 (.53%)
Gait Disturbance
3 (.53%)
Headache
3 (.53%)
Hypophagia
3 (.53%)
Liver Disorder
3 (.53%)
Nasopharyngitis
3 (.53%)
Night Sweats
3 (.53%)
Pancytopenia
3 (.53%)
Pneumothorax
3 (.53%)
Progressive Multifocal Leukoencepha...
3 (.53%)
Respiratory Distress
3 (.53%)
Respiratory Tract Infection
3 (.53%)
Tinnitus
3 (.53%)
Tremor
3 (.53%)
Vomiting
3 (.53%)
Abdominal Pain
2 (.35%)
Accidental Exposure
2 (.35%)
Adverse Event
2 (.35%)
Anaemia Haemolytic Autoimmune
2 (.35%)
Angioedema
2 (.35%)
Aplastic Anaemia
2 (.35%)
Ascites
2 (.35%)
Bleeding Time Prolonged
2 (.35%)
Bone Marrow Failure
2 (.35%)
Bone Neoplasm
2 (.35%)
Brain Oedema
2 (.35%)
Bronchopneumonia
2 (.35%)
Cardiac Arrest
2 (.35%)
Chills
2 (.35%)
Cholestasis
2 (.35%)
Chronic Lymphocytic Leukaemia
2 (.35%)
Convulsion
2 (.35%)
Coombs Positive Haemolytic Anaemia
2 (.35%)
Depression
2 (.35%)
Drug Effect Decreased
2 (.35%)
Drug Interaction
2 (.35%)
Dyskinesia
2 (.35%)
Ear Infection
2 (.35%)
Escherichia Sepsis
2 (.35%)
Eye Swelling
2 (.35%)
Febrile Neutropenia
2 (.35%)
Food Allergy
2 (.35%)
Haemolytic Anaemia
2 (.35%)
Haemorrhage
2 (.35%)
Inflammation
2 (.35%)
Influenza Like Illness
2 (.35%)
Jaundice
2 (.35%)
Jc Virus Infection
2 (.35%)
Leukaemia
2 (.35%)
Local Swelling
2 (.35%)
Lower Respiratory Tract Inflammatio...
2 (.35%)
Lung Infiltration
2 (.35%)
Lymphadenopathy Mediastinal
2 (.35%)
Lymphoma
2 (.35%)
Mediastinal Disorder
2 (.35%)
Muscle Twitching
2 (.35%)
Muscular Weakness
2 (.35%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Leukeran, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Leukeran is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Leukeran

What are the most common Leukeran adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Leukeran, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Leukeran is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Leukeran According to Those Reporting Adverse Events

Why are people taking Leukeran, according to those reporting adverse events to the FDA?

Chronic Lymphocytic Leukaemia
42
Drug Use For Unknown Indication
33
Non-hodgkins Lymphoma
12
Product Used For Unknown Indication
6
Behcets Syndrome
6
B-cell Lymphoma
6
Show More Show More
Crohns Disease
5
Nephrotic Syndrome
5
Hodgkins Disease
4
Rheumatoid Arthritis
4
Waldenstroms Macroglobulinaemia
3
Ill-defined Disorder
3
Chronic Lymphocytic Leukaemia Refra...
2
Drug Dispensing Error
2
Lymphocytic Leukaemia
2
Mantle Cell Lymphoma Stage Iv
2
Lymphoma
2
Autoimmune Disorder
1
Myeloid Leukaemia
1
Iga Nephropathy
1
Neoplasm Malignant
1
Musculoskeletal Pain
1
Multiple Myeloma
1
Hairy Cell Leukaemia
1
Leukaemia
1
Renal Disorder
1
Glomerulonephritis Proliferative
1
Haemolytic Anaemia
1

Drug Labels

LabelLabelerEffective
LeukeranGlaxoSmithKline LLC07-OCT-11
LeukeranAspen Global Inc.08-DEC-11

Leukeran Case Reports

What Leukeran safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Leukeran. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Leukeran.